Treatment duration: in clinical trials, treatment with SPRYCEL was continued until disease progression or until no longer tolerated by the patient.
Ravi kestus: kliinilistes uuringutes jätkati ravi SPRYCEL' iga kuni haiguse progresseerumiseni või seni, kuni patsient ravi enam ei talunud.